(Q34210036)

English

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

18

object named as

Kunle Odunsi

0 references

Christine Ambrosone

10

object named as

Christine Ambrosone

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

object named as

Sacha Gnjatic

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

8

object named as

Denise Frosina

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

13

object named as

Gerd Ritter

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

17

object named as

Lloyd J Old

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

15

object named as

Yao-Tseng Chen

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hiroyoshi Nishikawa

5

object named as

Hiroyoshi Nishikawa

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shashikant B Lele

14

object named as

Shashikant Lele

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Eiichi Sato

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sara H Olson

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jiyoung Ahn

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Brian Bundy

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Feng Qian

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Achim A Jungbluth

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

James Kepner

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tosin Odunsi

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Haruo Ohtani

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

12 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

18538-18543

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

The follow-up of ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Ovarian cancer: epidemiology, biology, and prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Tumor antigens recognized by T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Identification and intracellular location of MAGE-3 gene product

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Lymphocytic infiltration and survival in rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

5 July 2018

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

28 October 2018

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

28 October 2018

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

28 October 2018

Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

28 October 2018

New paths in human cancer serology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1311741

28 October 2018

CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16344461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4

1 reference

https://pubmed.ncbi.nlm.nih.gov/16344461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16344461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/16344461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16344461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16344461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.0509182102

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2005PNAS..10218538S

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34210036&oldid=1958098067"